![]() |
產(chǎn)地 | 進口、國產(chǎn) |
品牌 | 上海莼試 |
保存條件 | Store at -20 °C |
貨號 | CS11448 |
應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 |
CAS編號 | |
抗體名 | Anti-Tafazzin |
克隆性 | |
靶點 | 詳見說明書 |
適應(yīng)物種 | 詳見說明書 |
形態(tài) | 詳見說明書 |
宿主 | 詳見說明書 |
亞型 | IgG |
標識物 | 詳見說明書 |
濃度 | 1mg/1ml% |
免疫原 | KLH conjugated synthetic peptide derived from human Tafazzin |
技術(shù)外包服務(wù):
★Tafazzin蛋白抗體說明書 分子生物學:質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學:基因合成、引物合成、基因測序、載體構(gòu)建等
★蛋白工程:原核、哺乳動物蛋白表達系統(tǒng)等
★病毒包裝:腺病毒、慢病毒等
★抗體工程:磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細胞工程:細胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復、克隆形成)、細胞培養(yǎng)、細胞膜制備、穩(wěn)定細胞株構(gòu)建、細胞RNAi技術(shù)等等。
實驗流程:
Tafazzin蛋白抗體說明書 英文名稱 Anti-Tafazzin
中文名稱 Tafazzin蛋白抗體說明書
別 名 Barth syndrome; Cardiomyopathy dilated 3A (X linked); EFE2; Endocardial fibroelastosis 2; Protein G4.5; Tafazzin; TAZ; TAZ protein; TAZ protein; TAZ_HUMAN.
產(chǎn)品屬性:
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg 0.2ml/200μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human
產(chǎn)品類型 一抗
研究領(lǐng)域 信號轉(zhuǎn)導
蛋白分子量 predicted molecular weight: 33kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human Tafazzin
亞 型 IgG
純化方法 affinity purified by Protein A
儲 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
Tafazzin蛋白抗體說明書 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
(石蠟切片需做抗原修復)
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced; the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known.
Function : Some isoforms may be involved in cardiolipin (CL) metabolism.
Subcellular Location : Isoform 1: Membrane; Single-pass membrane protein.
Isoform 2: Cytoplasm (Probable).
Isoform 3: Membrane; Single-pass membrane protein.
Isoform 4: Membrane; Single-pass membrane protein.
Isoform 5: Membrane; Single-pass membrane protein.
Isoform 6: Cytoplasm (Probable).
Isoform 7: Membrane; Single-pass membrane protein.
Isoform 8: Cytoplasm (Probable).
Isoform 9: Cytoplasm (Probable).
Tissue Specificity : High levels in cardiac and skeletal muscle. Up to 10 isoforms can be present in different amounts in different tissues. Most isoforms are ubiquitous. Isoforms that lack the N-terminus are found in leukocytes and fibroblasts, but not in heart and skeletal muscle. Some forms appear restricted to cardiac and skeletal muscle or to leukocytes.
DISEASE : Barth syndrome (BTHS) [MIM:302060]: An X-linked disease characterized by dilated cardiomyopathy with endocardial fibroelastosis, a predominantly proximal skeletal myopathy, growth retardation, neutropenia, and organic aciduria, particularly excess of 3-methylglutaconic acid. Additional features include hypertrophic cardiomyopathy, isolated left ventricular non-compaction, ventricular arrhythmia, motor delay, poor appetite, fatigue and exercise intolerance, hypoglycemia, lactic acidosis, hyperammonemia, and dramatic late catch-up growth after growth delay throughout childhood. Note=The disease is caused by mutations affecting the gene represented in this entry.
Similarity : Belongs to the taffazin family.
Database links : UniProtKB/Swiss-Prot: Q16635.1
全、新、優(yōu)、品、好四大特點:
Tafazzin蛋白抗體說明書 全:公司提供上萬種產(chǎn)品,涵蓋了生物試劑,elisa試劑盒,標準品,培養(yǎng)基,原裝耗材,抗體、培養(yǎng)基、ATCC細胞等,基本上各種科研所需產(chǎn)品在我司都能找到。
新:產(chǎn)品更新速度較快,基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu):產(chǎn)品質(zhì)量好,投訴比較少。
好:我公司具有優(yōu)質(zhì)的技術(shù)團隊,產(chǎn)品一旦售出,實驗過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時沒有任何的后顧之憂。
正在熱銷的相關(guān)產(chǎn)品:
Anti-UG/FITC 熒光素標記子宮珠蛋白抗體IgGMulti-class antibodies規(guī)格: 0.2ml
CCR-7(CC chemokine receptor 7) CC趨化因子受體7(多肽)Multi-class antibodies規(guī)格: 0.5mg
組織蛋白酶K抗體 Anti-cath-K/CK 0.1ml
SEPT6 英文名稱: 細胞分化蛋白SEPT6抗體 0.2ml
EML3 英文名稱: 微管相關(guān)蛋白樣蛋白3抗體 0.2ml
Rhesus antibody Rh Phospho-Histone H3 (Thr3) 磷酸化組蛋白H3抗體 規(guī)格 0.1ml
CCR-7(CC chemokine receptor 7) CC趨化因子受體7(多肽)Multi-class antibodies規(guī)格: 0.5mg
Anti-Phospho-TLK1 (Ser695)/FITC 熒光素標記磷酸化調(diào)節(jié)染色體組裝激酶1抗體IgGMulti-class antibodies規(guī)格: 0.2ml
NT-3 神經(jīng)生長因子-3(抗原)Multi-class antibodies規(guī)格: 0.5mg
轉(zhuǎn)錄因子7類似物2抗體 anti-TCF7L2 0.2ml
phospho-SYN1(Ser549) 英文名稱: 磷酸化神經(jīng)突觸素1抗體 0.1ml
Ephrin B 英文名稱: Ephrin B抗體 0.1ml
Rhesus antibody Rh phospho-LKB1(Ser334) 磷酸化絲氨酸/蘇氨酸蛋白激酶抗體 規(guī)格 0.1ml
NT-3 神經(jīng)生長因子-3(抗原)Multi-class antibodies規(guī)格: 0.5mg
PTEN/MMAC1(CT)human, mo, rat, pig, dog, bovine, horse, chicken 一種抑制基因抗原(C端)Multi-class antibodies規(guī)格: 0.5mg
Anti-Bak Bcl-2同源拮抗劑抗體Multi-class antibodies規(guī)格: 0.1ml
Rhesus antibody Rh phospho-A Raf(Ser214) 磷酸化A-Raf抗體 規(guī)格 0.1ml
Keratin4 濃縮液 0.1ml 進口分裝
UBE2O 英文名稱: 泛素結(jié)合酶E2O抗體 0.2ml
CHST11 英文名稱: 碳水化合物磺基轉(zhuǎn)移酶11抗體 0.1ml
Anti-Bak Bcl-2同源拮抗劑抗體Multi-class antibodies規(guī)格: 0.1ml
IL5 Protein Human 重組人 IL5 / Ierleukin 5 蛋白
小鼠脈絡(luò)膜細胞完全培養(yǎng)基 100mL
IL9R Others Rat 大鼠 IL9R / Ierleukin 9 receptor 人細胞裂解液 (陽性對照)
A-431人表皮癌細胞 Human epidermoid carcinoma A-431 cells DMEM+10%FBS
CM-H052人胎盤絨毛膜細胞完全培養(yǎng)基100mL
人海馬星形膠質(zhì)細胞(HA-h)(1×106) 人平滑肌細胞 Human
CM-H100胎兒細胞完全培養(yǎng)基100mL
B2M Others Mouse 小鼠 B2M / Beta-2-microglobulin 人細胞裂解液 (陽性對照)
小鼠虹膜色素上皮細胞完全培養(yǎng)基 100mL
L1210小鼠細胞 L1210 mouse leukemia cells DMEM培養(yǎng)基+10%FBS
IL17A Protein Human 重組人 IL17 / IL17A 蛋白 (His 標簽)
人膠質(zhì)細胞(少突細胞)(HO) (1×106 ) 細胞名稱 種屬
Tafazzin蛋白抗體說明書 IL5 Protein Human 重組人 IL5 / Ierleukin 5 蛋白
小鼠脈絡(luò)膜細胞完全培養(yǎng)基 100mL
IL9R Others Rat 大鼠 IL9R / Ierleukin 9 receptor 人細胞裂解液 (陽性對照)
A-431人表皮癌細胞 Human epidermoid carcinoma A-431 cells DMEM+10%FBS
CM-H052人胎盤絨毛膜細胞完全培養(yǎng)基100mL
人海馬星形膠質(zhì)細胞(HA-h)(1×106) 人平滑肌細胞 Human